Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 6/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CDC14B | O60729 | 1/20 | 0.34 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26534864 | 0.83 | AHR (0.39) | AHRTTRSMN1; SMN2MAOAKDM4E | |
| SCHEMBL25733714 | 0.80 | CYP1A2 (0.40) | AHRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL18350128 | 0.79 | MAOA (0.45) | AHRTTRSMN1; SMN2MAOAKDM4E | |
| SCHEMBL25695847 | 0.79 | MAOA (0.37) | SMN1; SMN2MAOAKDM4EALDH1A1MAPT | |
| SCHEMBL17930626 | 0.78 | GPR3 (0.46) | AHRSMN1; SMN2MAOAKDM4EALDH1A1 | |
| SCHEMBL26534918 | 0.78 | AHR (0.35) | AHRKDM4E | |
| SCHEMBL26793003 | 0.78 | AHR (0.50) | AHRTTRSMN1; SMN2MAOAKDM4E | |
| SCHEMBL25733787 | 0.77 | AHR (0.51) | AHRTTRSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL16919420 | 0.77 | GPR3 (0.45) | AHRSMN1; SMN2MAOAKDM4EALDH1A1 | |
| SCHEMBL25620662 | 0.76 | MAOA (0.38) | MAOAKDM4EALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11814395-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11814395-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| WO-2023282511-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | AHR 3940/4885TTR 1148/4885SMN1; SMN2 2829/4885 |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | AHR 3940/4885TTR 1148/4885SMN1; SMN2 2829/4885 |
| US-11814395-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, MCM4 | AHR 1990/4885TTR 3534/4885SMN1; SMN2 4634/4885 |
| US-11877508-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | EMC1, EMC2, EPCAM | AHR 3940/4885TTR 1148/4885SMN1; SMN2 2829/4885 |
| US-20240217902-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, AOC1 | AHR 4050/4885TTR 1439/4885SMN1; SMN2 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.